April 25, 2024 19:38 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
'Biased, reflects poor understanding': India dumps US report on alleged rights abuse | Lok Sabha Elections 2024: ECI issues notices to BJP, Congress on complaints against Modi, Rahul | Massive landslide hits Arunachal Pradesh, a large section of Highway-33 washed away | Actress Tamannaah Bhatia summoned by Maharashtra cyber cell in 2023 illegal IPL streaming case | Bihar CM Nitish Kumar's party leader shot dead in Patna
Pfizer stops sale of Corex cough syrup in India after ban

Pfizer stops sale of Corex cough syrup in India after ban

India Blooms News Service | | 14 Mar 2016, 02:36 pm
Mumbai, Mar 14 (IBNS) Pharmaceutical major Pfizer has stopped manufacture and sale of popular cough syrup Corex with immediate effect after a ban by the Government.
“This is to inform you that the Government of India has prohibited the manufacture for sale, sale and distribution of fixed dose combination of Chlopheniramine Maleate + Codeine Syrup with immediate effect,” Pfizer said in a BSE filing on Monday.

 “In view of this, the company has discontinued the manufacture and sale of its drug Corex with immediate effect," it said.

Pfizer said it believed Corex had a "well-established efficacy and safety profile in India for more than 30 years," adding that the company was  "exploring all possible options at its disposal."

Pfizer said the prohibition on Corex  is likely to have an adverse impact on the revenue and profitability of the company.

 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.